These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17485508)

  • 1. Mass spectrometry-based systems approach for identification of inhibitors of Plasmodium falciparum fatty acid synthase.
    Sharma S; Sharma SK; Modak R; Karmodiya K; Surolia N; Surolia A
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2552-8. PubMed ID: 17485508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, characterization, and inhibition of Plasmodium falciparum beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ).
    Sharma SK; Kapoor M; Ramya TN; Kumar S; Kumar G; Modak R; Sharma S; Surolia N; Surolia A
    J Biol Chem; 2003 Nov; 278(46):45661-71. PubMed ID: 12930838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan.
    Kapoor M; Reddy CC; Krishnasastry MV; Surolia N; Surolia A
    Biochem J; 2004 Aug; 381(Pt 3):719-24. PubMed ID: 15086316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant expression and biochemical characterization of the unique elongating beta-ketoacyl-acyl carrier protein synthase involved in fatty acid biosynthesis of Plasmodium falciparum using natural and artificial substrates.
    Lack G; Homberger-Zizzari E; Folkers G; Scapozza L; Perozzo R
    J Biol Chem; 2006 Apr; 281(14):9538-46. PubMed ID: 16467310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the key residues in Plasmodium falciparum beta-ketoacyl acyl carrier protein reductase responsible for interactions with Plasmodium falciparum acyl carrier protein.
    Karmodiya K; Modak R; Sahoo N; Sajad S; Surolia N
    FEBS J; 2008 Oct; 275(19):4756-66. PubMed ID: 18721141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.
    Surolia N; Surolia A
    Nat Med; 2001 Feb; 7(2):167-73. PubMed ID: 11175846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-ketoacyl-ACP synthase I/II from Plasmodium falciparum (PfFabB/F)--is it B or F?
    Sharma S; Sharma SK; Surolia N; Surolia A
    IUBMB Life; 2009 Jun; 61(6):658-62. PubMed ID: 19472174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
    Banerjee T; Sharma SK; Surolia N; Surolia A
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.
    Kapoor M; Dar MJ; Surolia A; Surolia N
    Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity in fatty acid elongation enzymes: The FabB long-chain β-ketoacyl-ACP synthase I initiates fatty acid synthesis in Pseudomonas putida F1.
    Guo Q; Zhong C; Dong H; Cronan JE; Wang H
    J Biol Chem; 2024 Feb; 300(2):105600. PubMed ID: 38335573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fatty acid synthase: specific target for cancer therapy].
    Li XH; Hou YT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):1-5. PubMed ID: 12518220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.
    Surolia N; RamachandraRao SP; Surolia A
    Bioessays; 2002 Feb; 24(2):192-6. PubMed ID: 11835284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro reconstitution and steady-state analysis of the fatty acid synthase from Escherichia coli.
    Yu X; Liu T; Zhu F; Khosla C
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18643-8. PubMed ID: 22042840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.
    Suguna K; Surolia A; Surolia N
    Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.
    Kapoor M; Gopalakrishnapai J; Surolia N; Surolia A
    Biochem J; 2004 Aug; 381(Pt 3):735-41. PubMed ID: 15139852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of a Type I fatty acid synthase in Cryptosporidium parvum.
    Zhu G; Marchewka MJ; Woods KM; Upton SJ; Keithly JS
    Mol Biochem Parasitol; 2000 Feb; 105(2):253-60. PubMed ID: 10693747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early catalytic steps of Euglena gracilis chloroplast type II fatty acid synthase.
    Worsham LM; Williams SG; Ernst-Fonberg ML
    Biochim Biophys Acta; 1993 Sep; 1170(1):62-71. PubMed ID: 8399328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII.
    Prigge ST; He X; Gerena L; Waters NC; Reynolds KA
    Biochemistry; 2003 Feb; 42(4):1160-9. PubMed ID: 12549938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
    Tasdemir D; Lack G; Brun R; Rüedi P; Scapozza L; Perozzo R
    J Med Chem; 2006 Jun; 49(11):3345-53. PubMed ID: 16722653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.